Your browser doesn't support javascript.
loading
Development of low molecular weight heparin based nanoparticles for metastatic breast cancer therapy.
Sun, Haifeng; Cao, Dinglingge; Wu, Hao; Liu, Huan; Ke, Xue; Ci, Tianyuan.
Afiliação
  • Sun H; Department of Pharmaceutics, State Key Laboratory of Natural Medicines, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China.
  • Cao D; Department of Pharmaceutics, State Key Laboratory of Natural Medicines, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China.
  • Wu H; Department of Pharmaceutics, State Key Laboratory of Natural Medicines, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China.
  • Liu H; Department of Pharmaceutics, State Key Laboratory of Natural Medicines, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China.
  • Ke X; Department of Pharmaceutics, State Key Laboratory of Natural Medicines, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China. Electronic address: kexue1973@vip.sina.com.
  • Ci T; Department of Pharmaceutics, State Key Laboratory of Natural Medicines, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China. Electronic address: citianyuan_cpu@163.com.
Int J Biol Macromol ; 112: 343-355, 2018 Jun.
Article em En | MEDLINE | ID: mdl-29409771

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Doxorrubicina / Sistemas de Liberação de Medicamentos / Heparina de Baixo Peso Molecular Limite: Female / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Doxorrubicina / Sistemas de Liberação de Medicamentos / Heparina de Baixo Peso Molecular Limite: Female / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article